Biblio

Found 11 results
Sort by: Author Title Type [ Year (Desc)]
Filters: Author is Giovannoni, G  [Clear All Filters]
2011
Jackson SJ, Giovannoni G, Baker D. Fingolimod modulates microglial activation to augment markers of remyelination. J Neuroinflammation [Internet]. 2011;8:76-76. Available from: http://www.hubmed.org/display.cgi?uids=21729281
Ramagopalan SV, Hoang U, Seagroatt V, Handel A, Ebers GC, Giovannoni G, Goldacre MJ. Geography of hospital admissions for multiple sclerosis in England and comparison with the geography of hospital admissions for infectious mononucleosis: a descriptive study. J Neurol Neurosurg Psychiatry [Internet]. 2011;82:682-687. Available from: http://www.hubmed.org/display.cgi?uids=21212107
Al-Izki S, Pryce G, Jackson SJ, Giovannoni G, Baker D. Immunosuppression with FTY720 is insufficient to prevent secondary progressive neurodegeneration in experimental autoimmune encephalomyelitis. Mult Scler [Internet]. 2011;17:939-948. Available from: http://www.hubmed.org/display.cgi?uids=21459808
Hill-Cawthorne GA, Button T, Tuohy O, Jones JL, May K, Somerfield J, Green A, Giovannoni G, Compston DA, Fahey MT, et al. Long term lymphocyte reconstitution after alemtuzumab treatment of multiple sclerosis. J Neurol Neurosurg Psychiatry [Internet]. 2011. Available from: http://www.hubmed.org/display.cgi?uids=22056965
Tumani H, Deisenhammer F, Giovannoni G, Gold R, Hartung HP, Hemmer B, Hohlfeld R, Otto M, Stangel M, Wildemann B, et al. Revised McDonald criteria: the persisting importance of cerebrospinal fluid analysis. Ann Neurol [Internet]. 2011;70:520-520. Available from: http://www.hubmed.org/display.cgi?uids=21710627
Phillips JT, Giovannoni G, Lublin FD, O'Connor PW, Polman CH, Willoughby E, Aschenbach W, Pace A, Hyde R, Munschauer FE, et al. Sustained improvement in Expanded Disability Status Scale as a new efficacy measure of neurological change in multiple sclerosis: treatment effects with natalizumab in patients with relapsing multiple sclerosis. Mult Scler [Internet]. 2011;17:970-979. Available from: http://www.hubmed.org/display.cgi?uids=21421809
Disanto G, Handel AE, Morahan JM, Deluca GC, Kimball SM, Hypponen E, Giovannoni G, Ebers GC, Ramagopalan SV. Vitamin D and multiple sclerosis hospital admissions in Scotland. QJM [Internet]. 2011;104:1001-1003. Available from: http://www.hubmed.org/display.cgi?uids=21719427
2010
Peferoen LA, Lamers F, Lodder LN, Gerritsen WH, Huitinga I, Melief J, Giovannoni G, Meier U, Hintzen RQ, Verjans GM, et al. Epstein Barr virus is not a characteristic feature in the central nervous system in established multiple sclerosis. Brain [Internet]. 2010;133. Available from: http://www.hubmed.org/display.cgi?uids=19917644
Ramagopalan SV, Dyment DA, Giovannoni G, Sadovnick AD, Ebers GC. HLA-DRB1*15, low infant sibling exposure, and multiple sclerosis gene-environment interaction. Ann Neurol [Internet]. 2010;67:694-695. Available from: http://www.hubmed.org/display.cgi?uids=20437569
2009
Ramagopalan SV, Link J, Byrnes JK, Dyment DA, Giovannoni G, Hintzen RQ, Sundqvist E, Kockum I, Smestad C, Lie BA, et al. HLA-DRB1 and month of birth in multiple sclerosis. Neurology [Internet]. 2009;73:2107-2111. Available from: http://www.hubmed.org/display.cgi?uids=20018638
Guimond C, Dyment DA, Ramagopalan SV, Giovannoni G, Criscuoli M, Yee IM, Ebers GC, Sadovnick AD. Prevalence of MS in Iranian Immigrants to British Columbia, Canada. J Neurol [Internet]. 2009. Available from: http://www.hubmed.org/display.cgi?uids=20012309